On October 5, 2023, Reliq Health Technologies Inc., closed the transaction. The company issued 15,000,000 units at a price of CAD 0.40 per unit for gross proceeds of up to CAD 6,000,000. As a part of the transaction, the company paid CAD 480,000 as placement agent fee and non-transferrable options to purchase, at any time prior to the date that is 30 months from the closing date, that number of units equal to 8.0% of the number of units non-transferrable options to purchase, at any time prior to the date that is 30 months from the Closing Date, that number of Units equal to 8.0% of the number of units. The transaction is subject to the final approval of the Exchange. The transaction included participation from CEO Lisa Crossley for 250,000 Units. The company has received CAD 1,560,000 pursuant to Regulation D and included participation from 3 investors.

The TSX Venture Exchange has accepted for filing documentation with respect to a brokered private placement. The transaction included participation from 54 placees including existing insider involvement of one insider for 250,000.